In 2024, Michael F. Mahoney earned $24.82M in total compensation at Boston Scientific, including $1.40M salary, $3.74M bonus and $19.49M in stock. Most recently acquired 260,236 shares in Feb 2025. Currently holds stock worth $179.92M. Has donated $99.61M in stock to charitable causes. Has led Boston Scientific for over 13 years.
Compensation History
Annual executive compensation data for Michael F. Mahoney, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$24.82M
Salary
$1.40M
Bonus
$3.74M
Other
$193.39K
Salary
$1.40MBoard Justification
Our philosophy is to provide appropriate competitive compensation opportunities to our executives such that actual pay outcomes are heavily influenced by achievement of Company, business and individual performance targets and objectives, which are designed to support our business strategy and create long‐term stockholder value.
Bonus
$3.74MBoard Justification
The Applicable Distribution Percentage may be further modified based on the Company’s performance against Environmental, Social and Governance (ESG) and quality goals. In the 2024 ABP, we included Adjusted OIM as a financial performance metric to help drive the Company’s continued focus on adjusted operating margin expansion, and shifted the ESG scorecard to a modifier, whereby the distribution percentage amount may be increased or decreased based on the Company’s performance towards ESG goals.
Other Compensation
$193.39KBoard Justification
Amounts in the “All Other Compensation” column are composed of the following components: Match (401(k) Plan), Aircraft, Term Life Insurance, Financial Planning, Other
Restricted Stock
Board Justification
The amounts shown in this column represent the number of shares vested or earned multiplied by the closing price of our common stock on the vesting date.
Performance Metrics
Driving differentiated regional, business, and functional performance, Advancing category leadership, expanding into high-growth adjacencies, and enhancing our sales enabling digital capabilities, Driving global expansion, Driving profitability to fuel growth, Advancing our culture, our people capabilities, and our leadership pipeline, Progressing our ESG goals
Michael F. Mahoney
CEO of Boston Scientific
Education
Finance degree from the University of Iowa and an M.B.A. from Wake Forest University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
April 1, 1965 - 60 years ago
CEO of Boston Scientific for
13 years 1 month (Nov 2012 - Present)
Previous Experience
President of Johnson & Johnson's DePuy Orthopaedics
Other Boston Scientific CEOs
Holdings
Track Michael F. Mahoney's stock holdings and portfolio value over time.
Total Stock Sold
$157.28M
$157.28M
3,490,522 BSX shares
What if they kept their stock?
If Michael F. Mahoney didn't sell their stock, today they would have:
Extra BSX3,490,522 shares worth $340.40M.
This is 116.42% and $183.11M more than what they got when they sold the stock.
Charitable Transactions
1,021,385 shares
BSX
Recent Charitable Transactions
7,800 shares
BSX
Nov 26, 2024
Charity
176,245 shares
BSX
Aug 30, 2024
Charity
318,218 shares
BSX
Aug 30, 2023
Charity
365,457 shares
BSX
Sep 6, 2022
Charity
34,900 shares
BSX
Jan 1, 2022
Charity
34,965 shares
BSX
Jul 6, 2021
Charity
Insider Trading
Michael F. Mahoney's recent stock transactions, purchases, and sales filed with the SEC.
260,236 shares
BSX
Feb 11, 2025
Received
7,800 shares
BSX
Nov 26, 2024
Charity
$13.83M
BSX at $84.96/share
Nov 5, 2024
Sale
$13.78M
BSX at $84.63/share
Oct 7, 2024
Sale
$13.21M
BSX at $81.17/share
Sep 5, 2024
Sale
209,278 shares
BSX
Aug 30, 2024
Charity
176,245 shares
BSX
Aug 30, 2024
Charity
$500.29K
CVS at $54.49/share
May 2, 2024
Purchase
146,666 shares
BSX
Feb 6, 2024
Received
Rivals
Compare Michael F. Mahoney with competitor CEOs and industry peers.
Samuel N. Hazen
CEO of HCA Healthcare
2023 Compensation
Stock
$24.94M
Salary
$1.51M
Bonus
$5.03M
Other
$577.42K
Total Holdings
$24.53M
Joseph M. Hogan
CEO of Align Technology
2022 Compensation
Stock
$3.72M
Salary
$1.29M
Bonus
$0.00
Other
$17.73K
Total Holdings
$470.29K
Javier J. Rodriguez
CEO of DaVita
2022 Compensation
Stock
$0.00
Salary
$1.20M
Bonus
$0.00
Other
$610.78K
Total Holdings
$140.33M
Joseph W. Dziedzic
CEO of Integer Holdings
2022 Compensation
Stock
$0.00
Salary
$1.23M
Bonus
$0.00
Other
$97.75K
Total Holdings
$77.20M
Christophe Beck
CEO of Ecolab
2023 Compensation
Stock
$2.21M
Salary
$1.24M
Bonus
$3.73M
Other
$445.83K
Total Holdings
$39.42M